Study of Anti-HIVCellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus
| 針對症狀 | Anti-HIV |
| 臨床試驗編號 | NCT02766049 |
| 臨床階段 | Phase I/II |
| 臨床試驗位址 | University of Sao Paulo General Hospital |
| 目前研究進度 | This study has been completed. |
| 試驗開始日期 | May 9, 2016 |
| 試驗開始日期 | July 20, 2016 |
| 臨床目的 |
The aim of this study was to assess tolerability and safety of three different formulations of an anti-HIV immunotherapy based on autologous dendritic cells (DCs) pulsed with HIV chemically inactivated with Aldrithiol™-2 (AT-2). Patients were chronically infected with HIV, naïve for antiretroviral drugs. A possible immunological and virological favorable impact was also assessed. https://clinicaltrials.gov/ct2/show/NCT02766049?term=CELL&recrs=e&cond=AIDS&draw=2&rank=7 |